AstraZeneca Rating Reiterated by Shore Capital Stockbrokers (AZN)

Share on StockTwits

AstraZeneca (LON: AZN)‘s stock had its “buy” rating reaffirmed by investment analysts at Shore Capital Stockbrokers in a note issued to investors on Monday, Analyst Ratings.Net reports.

Shares of AstraZeneca (LON: AZN) opened at 3332.2881 on Monday. AstraZeneca has a one year low of GBX 2633.50 and a one year high of GBX 3544.50. The stock’s 50-day moving average is currently GBX 2919.40. The company’s market cap is £41.654 billion.

AZN has been the subject of a number of other recent research reports. Analysts at Galvan Research reiterated a “buy” rating on shares of AstraZeneca in a research note to investors on Monday. They now have a GBX 3,500 ($53.33) price target on the stock. Separately, analysts at UBS AG reiterated a “buy” rating on shares of AstraZeneca in a research note to investors on Friday. They now have a GBX 3,600 ($54.85) price target on the stock. Finally, analysts at AlphaValue reiterated a “reduce” rating on shares of AstraZeneca in a research note to investors on Wednesday, June 5th. They now have a GBX 3,371 ($51.36) price target on the stock.

Ten research analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of GBX 4,154.91 ($63.31).

AstraZeneca PLC (LON: AZN) is a global biopharmaceutical company.

Latest News

AB InBev Misses Earnings Estimates
AB InBev Misses Earnings Estimates
Samsung Promises Changes as Profit Plunges
Samsung Promises Changes as Profit Plunges
Advertising Revenue at Facebook Surges
Advertising Revenue at Facebook Surges
Lloyds Bank Cutting 9,000 Jobs and Closing Branches
Lloyds Bank Cutting 9,000 Jobs and Closing Branches
Goldman Sachs Cuts Forecast for Oil Price in 2015
Goldman Sachs Cuts Forecast for Oil Price in 2015
Eli Lilly Earnings Meet Expectations
Eli Lilly Earnings Meet Expectations


Leave a Reply

Advertisement
Advertisement
© 2006-2014 Ticker Report. Google+.